Onconic Therapeutics Inc. (KOSDAQ:476060)
South Korea · Delayed Price · Currency is KRW 14,220
-650 (-4.37%)
Oct 12, 2026, 3:30 PM KST
Onconic Therapeutics Market Cap
Onconic Therapeutics has a market cap or net worth of 645.7 billion as of October 12, 2026. It is the 14,941st most valuable company in the world and the 400th biggest in South Korea. Its market cap has decreased by 31.31% in one year.
Market Cap
645.70B
Enterprise Value
583.35B
Revenue
82.17B
Global Rank
Country Rank
#400 South Korea
PE Ratio
28.13
ChartMarket Cap Chart
Since December 19, 2024, Onconic Therapeutics's market cap has increased from 186.91B to 645.70B, an increase of 245.46%. That is a compound annual growth rate of 98.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 645.70B | -25.76% |
| Dec 30, 2025 | 869.78B | 392.69% |
| Dec 30, 2024 | 176.54B | -5.55% |
| Dec 19, 2024 | 186.91B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Komipharm International | 813.85B |
| Pharmicell | 727.85B |
| Chabiotech | 724.29B |
| Hyundai Bioscience | 611.83B |
| GI Innovation | 505.81B |
| AbClon | 490.82B |
| Proteina | 465.69B |
| GC Corp. | 435.33B |